Lupin (LUPIN) — Financial Results

1 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Lupin Limited reported Q3 FY2026 sales of ₹71,005 million, up 26.4% YoY, with net profit of ₹11,805 million, up 37.4% YoY. EBITDA surged 68.6% YoY to ₹23,766 million with margin expansion of 840 basis points. US sales reached a record ₹31,132 million (up 54%), while India grew 5.6%. The company took exceptional charges of ₹4,266 million. R&D investment was ₹5,352 million (7.5% of sales).

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Lupin Limited reported Q3 FY26 net sales of ₹71,005 million, growing 26% YoY, with net income of ₹11,756 million, up 38% YoY. EBITDA reached ₹22,095 million at 31.1% margin, reflecting strong operational performance. The US market drove growth with 52% YoY increase to ₹32,183 million, while India grew 6% YoY to ₹20,387 million. Key approvals included US FDA clearance for Armlupeg biosimilar and multiple plant compliance achievements. The company maintained its #3 US generics position by prescriptions and launched 13 products across India in nine months.

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 12 February 2026?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 12 February 2026

COALINDIA Coal India Limited Corporate Action COALINDIA Coal India Limited Corporate Action BAJFINANCE Bajaj Finance Limited Corporate Action TATASTEEL Tata Steel Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results DIVISLAB Divi's Laboratories Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.